@larmac – There is no question that the use of psychotropic drugs, illicit or otherwise, including cannabis and alcohol, can have deleterious effects on mood, and that the developing teen brain may be more susceptible to these effects. However, if there is to be any progress in mental health treatment to reduce harmful behaviours in youth, it becomes important to disentangle psychiatric drug treatment adverse effects from the reasons why the drug/s were first prescribed. There is a notable paper by Canadian child and adolescent psychiatrist Jane Garland -2001-where in case studies she describes, in my opinion, the emotional adverse effects described in the http://bit.ly/1cUYcSx story as, “existential crisis that is sort of, ‘I’m empty, I don’t know who I am, I don’t know where I’m going, I don’t have any grounding and I don’t know how to manage my negative feelings.” ABSTRACT A frontal lobe syndrome has previously been reported in adults treated with selective serotonin reuptake inhibitors (SSRIs), but not in children. Five typical cases of apathy and lack of motivation, one accompanied by disinhibition, are described in a child and four adolescents. Symptoms were dose related and reversible. The subtlety of symptoms, lack of insight in patients, disabling effects, and delayed onset indicate a need for clinicians to inform families of these potential symptoms when SSRIs are prescribed. Garland EJ1, Baerg EA, J Child Adolesc Psychopharmacol. 2001 Summer;11(2):181-6. It is important to read the scientific literature before putting the cart before the horse. Another fallacy is that SSRI-induced suicide only occurs within the first weeks of treatment. The FDA warnings clearly state times of dose change – increase or decrease – as high risk times. Abrupt discontinuation and restart may be catastrophic for some. To paraphrase Joseph Glenmullen in his book The Antidepressant Solution – they wouldn’t have put in that warning if they didn’t have to. Prescription drug safety, especially with youth suicide, should not be a zero sum game, and publicizing SSRI prescription-induced suicide should not be taboo.